Find uplifting stories about heroes, innovations, and solutions
21 results for "glp-1"
People using GLP-1 weight loss medications may not need weekly injections forever. A new study shows many patients maintain their weight loss while spacing out doses to every two or even six weeks.
Two pharmaceutical giants just released the first truly effective weight loss pills after years of failed attempts. The new medications could make obesity treatment as easy as taking a daily tablet.
Popular diabetes medications like Ozempic may fight substance addiction by targeting the brain's reward system. A study of 600,000 veterans found users faced lower risks of developing addictions and dying from overdoses.
A massive study of 600,000 veterans found that GLP-1 medications, commonly prescribed for weight loss and diabetes, cut addiction death rates in half. The drugs also reduced the risk of developing substance abuse problems by up to 25% across multiple substances.
A medication designed for diabetes is unexpectedly quieting cravings for alcohol, nicotine, and other addictive substances, offering hope where few treatments exist. New research shows it could save thousands of lives each year.
Weight loss medications like Ozempic and Mounjaro are showing remarkable promise in fighting addiction to all major substances, from alcohol to opioids. A study of over 600,000 veterans reveals these drugs reduce substance use disorders by blocking the cravings that fuel addiction.
People taking weight loss drugs like Wegovy are successfully maintaining their results by spacing out injections to every two weeks instead of weekly. A new study shows most patients kept the weight off and their health improvements without weekly shots.
New research suggests GLP-1 medications may help treat alcohol, opioid, and drug addictions by quieting cravings in the brain. A study of 600,000 veterans found fewer ER visits and deaths across all substance types.
A groundbreaking study of 600,000 veterans shows GLP-1 medications like Ozempic dramatically reduce substance use disorders and cut drug-related deaths in half. The discovery could revolutionize how we treat addiction.
ShopRite is giving free wellness kits to customers filling their first weight-loss medication prescription, complete with diet guides, protein samples, and grocery coupons. The East Coast grocery chain is meeting customers where they are as one in eight Americans now takes these medications.
A groundbreaking Harvard study reveals that people with type 2 diabetes who combine GLP-1 medications with healthy habits slash their heart attack and stroke risk by nearly half. The research shows modern medicine works best when paired with old-fashioned healthy living.
Doctors at Mayo Clinic are successfully pairing weight loss surgery with medications like Ozempic to help patients overcome obesity. This combined approach offers new hope for people who need more support than one treatment alone can provide.
Women taking Ozempic-type drugs with hormone therapy slashed their uterine cancer risk by two-thirds compared to hormones alone. The discovery could spare thousands from surgery and offer new protection against the most common gynecologic cancer.
A medication originally created for diabetes has become a life-changing treatment that helps people lose significant weight and quiet constant thoughts about food. Doctors are calling it one of the most important medical breakthroughs in a century, alongside insulin and penicillin. #
Millions of Americans have lost significant weight using GLP-1 medications like Ozempic and Wegovy, but keeping it off requires a smart, sustainable plan. Here's the hopeful science behind maintaining your success.
A biotech company is launching with a groundbreaking mission: using GLP-1 medications to treat substance use disorders instead of weight loss. Baseline Therapeutics could open new hope for millions struggling with addiction.
Doctors are discovering why weight-loss drugs work brilliantly for some people but fail for others. The answer could revolutionize how we treat obesity within just a few years.
Prostate cancer patients can now join a groundbreaking trial testing three simple strategies to protect their hearts while receiving lifesaving hormone therapy. City of Hope researchers are comparing intermittent fasting, GLP-1 medication, and heart-healthy lifestyle guidelines to keep patients healthier through treatment.
A breakthrough discovery reveals that widely available diabetes medications could help people with serious mental illness live significantly longer by addressing their greatest health threat. These patients typically lose 5 to 25 years of life to heart disease and metabolic conditions.
New real-world data shows many patients who stop taking popular weight loss drugs like Wegovy and Zepbound don't quickly regain the weight they lost. The findings challenge earlier concerns that the benefits disappear when treatment ends.
Showing 20 of 21